The RTS,S/AS01 (RTS,S) malaria vaccine is recommended by the World Health Organization (WHO) for children living in areas of moderate to high malaria transmission. Baral and co-authors evaluate the malaria vaccine introduction and delivery costs in the context of the pilot programs rolled out in Ghana, Kenya, and Malawi. Costs are estimated incremental to the national immunization programs from the government perspective. The authors found that the incremental cost per dose across the three countries is between $2.30 to $3.01 for the financial cost and the economic cost is three to four times the financial cost ($8.28 to $10.29). This is with the vaccine price assumed at $5 per dose. Procurement of vaccines and supplies represent between 50 and 82 % of the total economic cost. These findings are informative for other countries in the region making decisions on malaria vaccine introduction and scale up.
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.